Wastewater Surveillance of SARS-CoV-2 across 40 U.S. states.
Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
14 Mar 2021
14 Mar 2021
Historique:
pubmed:
25
3
2021
medline:
25
3
2021
entrez:
24
3
2021
Statut:
epublish
Résumé
Wastewater-based disease surveillance is a promising approach for monitoring community outbreaks. Here we describe a nationwide campaign to monitor SARS-CoV-2 in the wastewater of 159 counties in 40 U.S. states, covering 13% of the U.S. population from February 18 to June 2, 2020. Out of 1,751 total samples analyzed, 846 samples were positive for SARS-CoV-2 RNA, with overall viral concentrations declining from April to May. Wastewater viral titers were consistent with, and appeared to precede, clinical COVID-19 surveillance indicators, including daily new cases. Wastewater surveillance had a high detection rate (>80%) of SARS-CoV-2 when the daily incidence exceeded 13 per 100,000 people. Detection rates were positively associated with wastewater treatment plant catchment size. To our knowledge, this work represents the largest-scale wastewater-based SARS-CoV-2 monitoring campaign to date, encompassing a wide diversity of wastewater treatment facilities and geographic locations. Our findings demonstrate that a national wastewater-based approach to disease surveillance may be feasible and effective.
Identifiants
pubmed: 33758888
doi: 10.1101/2021.03.10.21253235
pmc: PMC7987047
pii:
doi:
Types de publication
Preprint
Langues
eng
Commentaires et corrections
Type : UpdateIn
Déclaration de conflit d'intérêts
Competing Interests MM and NG are cofounders of Biobot Analytics. EJA is advisor to Biobot Analytics. CD, KAM, KF, and NE are employees at Biobot Analytics, and all these authors hold shares in the company.